If you or a loved one have taken (or affected by) Invokana after March 2013 please contact us today.
Invokana Linked to Potentially Fatal Ketoacidosis
Type 2 diabetes patients who are taking Invokana to control blood sugar levels could be at risk for developing a serious condition known as ketoacidosis that can lead to brain swelling, coma and even death. If you are currently taking this drug, read on to find out more about the potential dangers and side effects of this medication. You could be entitled to compensation for any injuries you’ve suffered.
What is Invokana?
Manufactured by Janssen Pharmaceuticals and released in March 2013, Invokana is an oral medication prescribed to reduce blood sugar in patients with Type 2 diabetes. As the first SGLT2 inhibitor approved by the FDA, Invokana works by blocking the reabsorption of glucose in the kidneys and increasing glucose secretion. Excess blood sugar is expelled through urination.
What are the risks?
The FDA warns that patients taking Invokana are at risk for developing a serious condition known as ketoacidosis, that can cause severe dehydration, dangerous brain swelling, coma and death. Ketoacidosis occurs when sugar cannot be used as a fuel source in the body due to too little or no insulin. As the body breaks down fat to use as an alternative fuel source, it produces a waste product called ketones. As ketones build up in the bloodstream, they become toxic to the body. This condition is an emergency and can lead to death if not treated promptly. Common warning signs of ketoacidosis include abdominal pain, confusion, unexplained fatigue, dehydration, and vomiting.